Suppliers of the Year recognized by HealthTrust Performance Group; Mass. invests in nursing; plus Jobs!

July 21, 2023

Hello NAW Subscribers -

I hope you like this issue of National Accounts Weekly.

Sincerely,

John Pritchard

President of ANAE

Publisher of The Journal of Healthcare Contracting

The Journal of Healthcare Contracting: July 2023

Cover Story: HIRC Awards Transparency Partner Badges

Sponsored - Cardinal: The Cost of a Fragmented Lab Supply Chain

Trends: Medical Dental Integration

Sponsored - Thermo Fisher: The Need for Automation in the Lab

Healthcare Workforce: IDN Solutions to the Nursing Shortage

Supply Chain: Increasing American Manufacturing in the Wake of COVID-19

Read the Issue Here

Intermountain Health Transplant Program performs 600th life-saving heart transplant

The Intermountain Health Heart Transplant Program has achieved a major medical milestone – performing the program’s 600th adult life-saving heart transplant and marking its 38th anniversary as one of the top cardiovascular transplant programs in the country.

Over the past 38 years, the Intermountain Heart Transplant Program has grown into a national model and is recognized as a center of excellence with high-quality outcomes and excellent survival rates post-transplant, which are among the highest in the nation.

HealthTrust Performance Group recognizes Suppliers of the Year for 2023

HealthTrust Performance Group, a leading healthcare performance improvement organization, has named Agiliti, Insight Direct USA, Meitheal Pharmaceuticals, and Merck as Suppliers of the Year for 2023. Nominations were reviewed and winners selected by the HealthTrust Supply Chain Board. Recipients of the 2023 awards were announced during the annual HealthTrust University Conference in Las Vegas.

Supplier of the Year designations were awarded in four categories to the following companies and their representatives attending HealthTrust University Conference.

New Survey!

Voice Your Opinion!

Hello National Account Superstars!

I screwed up! Big time! But you can bail me out if you would be so kind…

The last survey results (about industry meetings and how often you meet with IDNs) were inadvertently erased before I compiled them.

Such a rookie mistake, I know. I am very sorry. If you would be so kind...

Please retake it here.

It will take you less than one minute, I promise. I will only share the results with those that participate.

Here is a new survey for this week! It explores more industry meetings.

How often you meet with GPOs, IDN owned GPOs and more.

You can take this survey here.

It will take you less than one minute, I promise. I will only share the results with those that participate.

Thanks for understanding!

Please let me know if I can do anything for you!

John

Take the 1-Minute Survey Here!

Children’s Hospital Association names Matt Cook as CEO

Children’s Hospital Association has named Matt Cook as chief executive officer effective Oct. 16. Cook will join CHA after serving as president of UCSF Benioff Children’s Hospitals and senior vice president of Children’s Services at UCSF Health where he oversees strategic direction, operations, and clinical services for pediatric care in Oakland and San Francisco.

Prior to Cook’s role at UCSF, he served as president of Riley Children’s Health. He also served as chief strategy officer for Indiana University Health, where he provided strategic direction and leadership for pediatric services throughout the state’s largest health system. Before his time in Indianapolis, Cook was executive vice president of strategic planning and business development at Children’s Hospital of Philadelphia and spent nine years as a principal at the Chartis Group, a health care consulting firm based in Chicago.

Emory Healthcare appoints Amaka Eneanya as chief transformation officer

Emory Healthcare, the most comprehensive academic health system in Georgia, has announced the appointment of Amaka Eneanya, MD, MPH, as chief transformation officer for Emory Healthcare, effective July 16.

The newly created position will have a focus on enhancing both patient and clinician experiences at Emory. In that respect, Eneanya will lead the development of systemwide strategies to bolster the patient experience through improved patient access, increase community engagement and outreach and enrich the overall clinician experience at Emory. She will also collaborate with Emory’s Diversity, Equity and Inclusion Office to prioritize strategies that center around health equity, diversity and inclusion in the delivery of patient care.

UMass Boston, Mass General Brigham to invest in nursing clinical-to-career pathway

Mass General Brigham and UMass Boston’s Manning College of Nursing and Health Sciences today announced an expanded collaboration to enhance the college’s Clinical Leadership Collaborative for Diversity in Nursing program.

With a $20 million investment -- $10 million from Mass General Brigham and $10 million from UMass Boston -- the goal is to recruit and retain nursing students from underrepresented communities as they start their clinical rotations.

Midmark appoints Matthew Logan as VP of marketing

Midmark announced Matthew Logan as vice president, marketing. In this role, Logan will help create and shape strategies that will expand and amplify the company’s standing as the industry leader in improving the experience between the patient and the caregiver at the point of care.

Logan comes to Midmark after a successful stint as vice president of marketing at Roche Diagnostics Corporation, which develops and produces medical tests and digital tools to help healthcare professionals find the right treatment for patients. Collaborating across sales, marketing, implementation and customer service functions, he spearheaded the creation of a new end-to-end process for the launch of the next generation of connected diagnostic devices and IT solutions. He was also instrumental in helping the company create a competitive advantage through the customer experience.

Sekisui Diagnostics appoints Luke Christensen as global VP of sales

Sekisui Diagnostics announced that Luke Christensen joined the company on July 6 as the Global Vice President of Sales.

Christensen will be responsible for managing the IVD business sales as well as having shared responsibility for portions of the diagnostic enzyme sales ensuring the successful execution of the company’s sales strategy and for managing the budget for his areas of responsibility. Christensen brings with him over 20 years of sales experience as a leader with a solid history of growth and active participation in advancing the interests of Laboratory based businesses.